Impact Of COVID-19 Pandemic On The Pattern Of Azithromycin Prescribing; A Review
Najla Saeed Dar-Odeh, Osama Abdalla Abu-Hammad, Nebras Mohammed Althagafi, Shaden Abu‐Hammad, Rawah Talal Eshky, Ismail Mahmoud Abdouh, Mona M. Aboelnagga, Abdalla Abu-Hammad · The International Arabic Journal of Antimicrobial Agents · 2022
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
The International Arabic Journal of Antimicrobial Agents · OpenAlex · review · 2022
Abstract
Objective: Emergence of COVID-19 infection and its persistence globally for three years in a row (2020-2022) entailed several modifications in healthcare services, among which drug prescribing was an important outcome. This review aims to highlight changing trends in azithromycin prescribing during pandemic years. Methods: PubMed database was systematically searched for combinations of the following keywords: Antibiotics; Antimicrobial resistance; Azithromycin; COVID-19. Results: A total of 12 articles were included in this review. All included studies demonstrated a notable increase in azithromycin consumption during COVID-19 pandemic in Spain, Brazil, USA, India, Croatia, and Jordan.
Healthcare systems worldwide should be prepared to address anticipated outcomes of increased azithromycin use particularly possible changing trends in azithromycin resistance, and systemic side effects of the drug.
Open the resolved locator · 10.3823/866
Metadata licence: OpenAlex metadata (CC0)